Deans' stroke musings: Whole food versus supplement: Comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, October 2, 2015

Whole food versus supplement: Comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors

Lycopene is very important to us in stroke risk reduction even if your doctor hasn't added it to your non-existant stroke diet protocol.

Lycopene in tomatoes reduces stroke risk by more than 50%

http://www.mdlinx.com/internal-medicine/medical-news-article/2014/09/29/cardiovascular-risk-factors/5562892/?

Advances in Nutrition: An International Review Journal, 09/29/2014 BurtonFreeman BM, et al. –

In this study, authors want to compare the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. With the exception of blood pressure management where lycopene supplementation was favored, tomato intake provided more favorable results on cardiovascular risk endpoints than did lycopene supplementation. Indeed, future research that is well designed, clinically focused, mechanistically revealing, and relevant to human intake will undoubtedly add to the growing body of knowledge unveiling the promise of tomatoes and/or lycopene supplementation as an integral component of a heart–healthy diet.

Cardiovascular disease (CVD) is a major contributor to morbidity and mortality in the United States and worldwide.
A link between diet and CVD is well established, with dietary modification a foundational component of CVD prevention and management.
With the discovery of bioactive components beyond the essential nutrients of foods, a new era of nutritional, medical, botanical, physiologic, and analytical sciences has unfolded.
The ability to identify, isolate, purify, and deliver single components has expanded the dietary supplement business and health opportunity for consumers.
Lycopene is an example of a food component that has attracted attention from scientists as well as food, agriculture, and dietary supplement industries.
A major question, however, is whether delivering lycopene through a supplement source is as effective as or more effective than consuming lycopene through whole food sources, specifically the tomato, which is the richest source of lycopene in the Western diet.
In this review, authors examined clinical trials comparing the efficacy of lycopene supplements with tomato products on intermediate CVD risk factors including oxidative stress, inflammation, endothelial function, blood pressure, and lipid metabolism.
Overall, the present review highlights the need for more targeted research; however, at present, the available clinical research supports consuming tomato–based foods as a first–line approach to cardiovascular health.